Director · Nurix Therapeutics, Inc. · Nurix Therapeutics, Inc. — Director Stock Option (right to buy)
Side
A
Value
—
Shares
31.3K
Price
—
Executed
May 15, 2026
Disclosed
May 15, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
May 15 executedMay 15, 2026 disclosed
NRIX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Nurix Therapeutics, Inc. — Director Stock Option (right to buy)
Ticker
NRIX
Shares
31.3K
Price per share
$0
Execution date (reported)
May 15, 2026
Owned after transaction
31.3K shares
Days from execution to publication
0
What this establishes
Saltzman Edward C filed this Form 4 reporting a grant or award of NRIX on May 15, 2026. It became public on May 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Saltzman Edward Ccik:0001946233
Issuer
Nurix Therapeutics, Inc.cik:0001549595
Revision history · 0
No field has changed since this record was first ingested.
